NCT03886350View on ClinicalTrials.gov

Implication of UNconventionaL T Lymphocytes in Cystic Fibrosis (UNLOCk)

CompletedOBSERVATIONAL
Enrollment

62

Participants

Timeline

Start Date

April 3, 2019

Primary Completion Date

July 16, 2020

Study Completion Date

July 20, 2020

Conditions
Cystic FibrosisInnate ImmunityInflammatory Response
Interventions
OTHER

blood and sputum samples

Blood and sputum samples for research purpose collected during routine tests performed at steady state and acute exacerbation

Trial Locations (2)

37044

Cystic Fibrosis Resource and Competence Center, University Hospital, Tours, Tours

Pulmonology Department, University Hospital, Tours, Tours

All Listed Sponsors
lead

University Hospital, Tours

OTHER

NCT03886350 - Implication of UNconventionaL T Lymphocytes in Cystic Fibrosis (UNLOCk) | Biotech Hunter | Biotech Hunter